N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143124 |
| CAS No | NA |
| Mol.F. | C28H24N4O6 |
| Mol.Wt. | 512.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143125 |
| CAS No | NA |
| Mol.F. | C36H29N5O9 |
| Mol.Wt. | 675.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143126 |
| CAS No | NA |
| Mol.F. | C17H14FN3O4 |
| Mol.Wt. | 343.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143127 |
| CAS No | NA |
| Mol.F. | C23H21N3O7 |
| Mol.Wt. | 451.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143128 |
| CAS No | NA |
| Mol.F. | C28H23FN4O7 |
| Mol.Wt. | 546.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143129 |
| CAS No | NA |
| Mol.F. | C28H23ClN4O6 |
| Mol.Wt. | 520.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143130 |
| CAS No | NA |
| Mol.F. | C22H26N2O5 |
| Mol.Wt. | 398.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143131 |
| CAS No | NA |
| Mol.F. | C22H25FN2O5 |
| Mol.Wt. | 416.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143132 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O5 |
| Mol.Wt. | 434.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143133 |
| CAS No | NA |
| Mol.F. | C7H12N2O4 |
| Mol.Wt. | 188.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143134 |
| CAS No | NA |
| Mol.F. | C29H52N2O6 |
| Mol.Wt. | 524.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143135 |
| CAS No | NA |
| Mol.F. | C37H63N3O6 |
| Mol.Wt. | 645.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143136 |
| CAS No | NA |
| Mol.F. | C8H15N3O5 |
| Mol.Wt. | 233.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143137 |
| CAS No | NA |
| Mol.F. | C16H17ClN2O2 |
| Mol.Wt. | 304.77 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143138 |
| CAS No | NA |
| Mol.F. | C17H17N5O2S |
| Mol.Wt. | 355.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143139 |
| CAS No | NA |
| Mol.F. | C12H10N4OS |
| Mol.Wt. | 258.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |